Genscript Biotech Corporation ( GNNSF) - Key Metrics
GNNSF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.18 | -$0.06 | $0 | $0 |
| 2025Q4 | $0.20 | -$0.23 | $0.05 | $0.03 |
| 2025Q2 | $0.44 | -$0.02 | $0.20 | $0.17 |
| 2024Q4 | $0.02 | $1.48 | $0 | -$0.01 |
| 2024Q2 | $0.27 | -$0.08 | $0.04 | -$0.03 |
GNNSF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -6.78 |
| 2025Q4 | 0% | -1.80 |
| 2025Q2 | 0% | -46.61 |
| 2024Q4 | 0% | 0.21 |
| 2024Q2 | 0% | -4.84 |
GNNSF
Price: $3.70
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.25 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 7.0 billion